Syndrome development and treatment with BPC 157 have been demonstrated in a variety of procedures inducing vessel occlusion (Vukojevic et al., 2018
27 : 854862 Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H
Weve then assumed that 30% of these people will ultimately end up on GLP-1 receptor agonist drugs, or 3.3m people, which is around 5% of the overall population
Possible side effects of GLP-1 drugs include: Nausea Vomiting Diarrhea Constipation Loss of body weight, including muscle Increases in fertility Changes in appetite and food preferences Changes in mood
To explore deeper, we all possess this specific enzyme called CYP1A2, which essentially dictates how well we metabolize caffeine